庞利红;黄丽娜;富奇志;

• 1:河南科技大学第二附属医院神经内科
• 2:河南科技大学第一附属医院神经内科

摘要(Abstract)：

目的研究发病4.5h内的急性脑梗死患者使用rt-PA静脉溶栓的疗效。方法 2015-06—2016-12收治的发病4.5h内急性脑梗死患者125例,分为溶栓组65例和对照组60例。溶栓组给予rt-PA静脉溶栓及脑梗死常规治疗,对照组给予阿司匹林及其他常规治疗。2组分别在治疗前和治疗后24h和7d进行NIHSS评分。结果治疗前后溶栓组的NIHSS评分改善明显,与对照组比较,差异有统计学意义(P<0.05)。结论急性脑梗死患者发病在4.5h内应用rt-PA静脉溶栓有显著临床疗效。

关键词(KeyWords)： 急性脑梗死;时间窗;rt-PA;静脉溶栓;疗效

Abstract:

Keywords:

基金项目(Foundation): 河南省重点科技攻关项目,编号:132102310167

作者(Authors): 庞利红;黄丽娜;富奇志;

参考文献(References)：

• [1]MICIELI G,MARCHESELLI S,TOSI P A.Safety and efficacy of alteplase in the treatment of acute ischemic stroke[J].Vasc Health Risk Manag,2009,5(1):397-409.
• [2]Tissue plasminogen activator for acute ischemic stroke.The National Institute of Neurological Disordors and Stroke rt-PA Stroke Study Group[J].N Engl J Med,1995,333(24):1 581-1 587.
• [3]REEVES M J,ARORA S,BRODERICK J P,et al.Acute stroke care in the US:results from 4pilot prototypes of the Paul Coverdell national acute stroke registry[J].Stroke,2005,36(6):1 232-1 240.
• [4]中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J].中华神经科杂志,2010,43(2):146-153.
• [5]王伊龙.临床应用重组组织型纤溶酶原激活剂静脉溶栓治疗缺血性卒中专家共识[J].中华内科杂志,2006,45(7):613-614.
• [6]中华神经科学会,中华神经外科学会.脑卒中患者临床神经功能缺损程度评分标准[J].中华神经科杂志,1996,29(6):381-383.
• [7]WANG Y,LIAO X,ZHAO X,et al.Using recombinant tissue plasminogen activator to treat acute ischemic stroke in China:analysis of the results from the Chinese National Stroke Registry(CNSR)[J].Stroke,2011,42(6):1 658-1 664.
• [8]LIANG J,LIU W,SUN J,et al.Analysis of the risk factors for the short-term prognosis of acute ischemic stroke[J].Int J Clin Expe,2015,8(11):21 915-21 924.
• [9]贺茂林.脑血管疾病//贾建平,陈生弟.神经病学[M].7版.北京:人民卫生出版社,2013:170.
• [10]WANG Y L,WU D,LIAO X,et al.Burden of stroke in china[J].Int J Stroke,2007,2(3):211-213.
• [11]BELAYEV L,ZHAO W,BUSTO R,et al.Transient middle cerebral artery occlusion by intraluminal suture,I:three-dimensional autoradiographic image-analysis of local cerebral glucose metabolism-blood flow interrelationships during ischemia and early recirculation[J].Cereb Blood Flow Metab,1997,17(12):1 266-1 280.
• [12]ASTRUP J,SIESIO B K,SYMON L.Thresholds in cerebral isehemia-the ischemic Penumbra[J].Stroke,1981,12(6):723-725.
• [13]MAGGIONI A P,LATINI R,CARSON P E,et al.Valsartan reduces the incidence of atrial fibrillation in patients with heart failure:results from the valsartan heart filure trail(Val-HeFT)[J].Am Heart J,2005,149(3):548-557.
• [14]DAVIS S M,DORMAN G A,BUTCHER K S,et al.Selection of thrombolytic therapy beyond 3 h using magnetic resonance imaging[J].Curr Opin Neurol,2005,18(1):47-52.
• [15]JAUCH E C,SAVER J L,JR ADAMS H P,et al.Guidelines for the early managemem of patients with acute ischemic stroke:aguideline for healthcare professionals from the American Heart Association/American Stroke Association[J].Stroke,2013,44(3):870-947.
• [16]CICCONE A,VALVASSORI L,NICHELATTI M,et al.Endovascular treatment for acute ischemic stroke[J].N Engl J Med,2013,368(10):904-913.
• [17]SONG D,CHO A H.Previous and Recent Evidence of EndovaScular Therapy in Acute Ischemic Stroke[J].Neurointer Vention,2015,10(2):51-59.
• [18]PLANCHE T,AGHAIZU A,HOLLIMAN R,et al.Diagnosis of clostridium difficile infection by toxin detection kits:a systematic review[J].Lancet Infect Dis,2008,8(12):777-784.
• [19]ALBERS G W,BATES V E,CLARK W M,et al.Intravenous tissue-type plasminogen activator for treatment of acute stroke:the Standard Treatment with Alteplase to Reverse Stroke(STARS)study[J].JAMA,2000,283(9):1 145-1 150.
• [20]MITEFF F,LEVI C L,BATEMAN G A,et al.The independent predictive utility of computed tomography angiographic collateral status in acute ischaemic stroke[J].Brain,2009,132(Pt 8):2 231-2 238.